Elevance Health Inc. (ELV) Tops Q1 EPS by 15c

Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $9.46, $0.15 better than the analyst estimate of $9.31. Revenue for the quarter came in at $41.9 billion versus the consensus estimate of $40.92 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral